Join to view full profile
300 E 66th StNew York, NY 10065
Phone+1 646-227-3228
Dr. Lieberman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Maimonides Medical CenterFellowship, Hematology and Medical Oncology, 2023 - 2026
SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 2020 - 2023
Tel Aviv University SacklerClass of 2020
Certifications & Licensure
NJ State Medical License 2026 - 2027
NY State Medical License 2022 - 2027
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 11 citationsTrastuzumab Deruxtecan Resistance via Loss of HER2 Expression and Binding.Wanyi Chen, Avantika Gupta, Nicholas Mai, Sharanya Nag, Joshua S Lau
Cancer Discovery. 2026-02-06 - 5 citationsSequential Antibody-Drug Conjugate Therapy in Patients With Metastatic Breast Cancer Treated With Sacituzumab Govitecan and Trastuzumab Deruxtecan.Nicholas Mai, Miriam M Klar Lieberman, Emanuela Ferraro, Maria Bromberg, Yuan Chen
JCO Precision Oncology. 2025-05-01 - 5 citationsShifting from vitamin K antagonists to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: predictors, patterns and temporal trends.Arthur Shiyovich, Varda Shalev, Gabriel Chodick, Matanya Tirosh, Amos Katz
BMC Cardiovascular Disorders. 2021-10-13
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:



